Stay updated on Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for a completed Phase 2 study of nivolumab and daratumumab, with or without low-dose cyclophosphamide, is available. It includes the study design, eligibility criteria, treatment arms, outcomes, and participating locations.
    Difference
    54%
    Check dated 2026-11-09T13:30:13.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision indicator changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T13:17:13.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    An NIH banner announces a website transition and says NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).
    Difference
    1%
    Check dated 2026-10-26T14:42:49.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2 while the page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:32:17.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T14:36:50.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error for the study record, indicating an access-restricted state rather than new study content. The added content reflects the error state with standard navigation and revision information.
    Difference
    19%
    Check dated 2026-09-21T20:57:38.000Z thumbnail image

Stay in the know with updates to Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial page.